Pfizer PFE and BioNTech BNTX announced that they are planning to test a three-dose regimen of their COVID-19 vaccine, Comirnaty (BNT162b), in children aged six months to five years, following routine ...
(AP) – A real-world test of Pfizer’s COVID-19 vaccine in more than half a million people confirms that it’s very effective at preventing serious illness or death, even after one dose. Wednesday’s ...
Pfizer and BioNTech are testing a third dose of their Covid-19 vaccine in an ongoing trial of children ages 6 months to under 5 years after the companies found that the two-dose regimen didn’t ...
On January 2, 2022, Israel began administering a fourth dose of BNT162b2 vaccine to persons 60 years of age or older. Data are needed regarding the effect of the fourth dose on rates of confirmed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results